important side effect informationbefore taking imbruvica ® tell your healthcare provider about all of your medical conditions including if youhave had recent surgery or plan to have surgery your healthcare provider may stop imbruvica ® for any planned medical surgical or dental procedurehave bleeding problemshave or had heart rhythm problems smoke or have a medical condition that increases your risk of heart disease such as high blood pressure high cholesterol or diabeteshave an infectionhave liver problemsare pregnant or plan to become pregnant imbruvica ® can harm your unborn baby if you are able to become pregnant your healthcare provider will do a pregnancy test before starting treatment with imbruvica ®females should not become pregnant during treatment and for 1 month after the last dose of imbruvica ®males should avoid getting female partners pregnant during treatment and for 1 month after the last dose of imbruvica ®are breastfeeding or plan to breastfeed you and your healthcare provider should decide if you will take imbruvica ® or breastfeed tell your healthcare provider about all the medicines you take including prescription and overthecounter medicines vitamins and herbal supplements taking imbruvica ® with certain other medicines may affect how imbruvica ® works and can cause side effects how should i take imbruvica ® take imbruvica ® exactly as your healthcare provider tells you to take it take imbruvica ® 1 time a day swallow imbruvica ® capsules and tablets whole with a glass of water do not open break or chew imbruvica ® capsules do not cut crush or chew imbruvica ® tablets take imbruvica ® at about the same time each day if you miss a dose of imbruvica ® take it as soon as you remember on the same day take your next dose of imbruvica ® at your regular time on the next day do not take extra doses of imbruvica ® to make up for a missed dose if you take too much imbruvica ® call your healthcare provider or go to the nearest hospital emergency room right away what should i avoid while taking imbruvica ® you should not drink grapefruit juice eat grapefruit or eat seville oranges often used in marmalades during treatment with imbruvica ® these products may increase the amount of imbruvica ® in your blood what are the possible side effects of imbruvica ® imbruvica ® may cause serious side effects including bleeding problems hemorrhage are common during treatment with imbruvica ® and can also be serious and may lead to death your risk of bleeding may increase if you are also taking a blood thinner medicine tell your healthcare provider if you have any signs of bleeding including blood in your stools or black stools looks like tar pink or brown urine unexpected bleeding or bleeding that is severe or that you cannot control vomit blood or vomit looks like coffee grounds cough up blood or blood clots increased bruising dizziness weakness confusion change in your speech or a headache that lasts a long time infections can happen during treatment with imbruvica ® these infections can be serious and may lead to death tell your healthcare provider right away if you have fever chills weakness confusion or other signs or symptoms of an infection during treatment with imbruvica ®decrease in blood cell counts decreased blood counts white blood cells platelets and red blood cells are common with imbruvica ® but can also be severe your healthcare provider should do monthly blood tests to check your blood counts heart rhythm problems ventricular arrhythmias atrial fibrillation and atrial flutter serious heart rhythm problems and death have happened in people treated with imbruvica ® especially in people who have an increased risk for heart disease have an infection or who have had heart rhythm problems in the past tell your healthcare provider if you get any symptoms of heart rhythm problems such as feeling as if your heart is beating fast and irregular lightheadedness dizziness shortness of breath chest discomfort or you faint high blood pressure hypertension new or worsening high blood pressure has happened in people treated with imbruvica ® your healthcare provider may start you on blood pressure medicine or change current medicines to treat your blood pressure second primary cancers new cancers have happened during treatment with imbruvica ® including cancers of the skin or other organs tumor lysis syndrome tls tls is caused by the fast breakdown of cancer cells tls can cause kidney failure and the need for dialysis treatment abnormal heart rhythm seizure and sometimes death your healthcare provider may do blood tests to check you for tls the most common side effects of imbruvica ® in adults with bcell malignancies mcl cllsll wm and mzl include diarrhea bruising muscle and bone pain tiredness rash fever nausea the most common side effects of imbruvica ® in adults with c gvhd include tiredness bruising diarrhea mouth sores stomatitismuscle spasms nausea pneumonia diarrhea is a common side effect in people who take imbruvica ® drink plenty of fluids during treatment with imbruvica ® to help reduce your risk of losing too much fluid dehydration due to diarrhea tell your healthcare provider if you have diarrhea that does not go away these are not all the possible side effects of imbruvica ® call your doctor for medical advice about side effects you may report side effects to fda at 1800fda1088 general information about the safe and effective use of imbruvica ®medicines are sometimes prescribed for purposes other than those listed in a patient information leaflet do not use imbruvica ® for a condition for which it was not prescribed do not give imbruvica ® to other people even if they have the same symptoms that you have it may harm them you can ask your pharmacist or healthcare provider for information about imbruvica ® that is written for health professionals please see the full important product information indicationswhat is imbruvica ® ibrutinib imbruvica ® ibrutinib is a prescription medicine used to treat adults with mantle cell lymphoma mcl who have received at least one prior treatment chronic lymphocytic leukemia cllsmall lymphocytic lymphoma sllchronic lymphocytic leukemia cllsmall lymphocytic lymphoma sll with 17p deletion waldenströms macroglobulinemia wmmarginal zone lymphoma mzl who require a medicine by mouth or injection systemic therapy and have received a certain type of prior treatment chronic graft versus host disease c gvhd after failure of 1 or more lines of systemic therapy it is not known if imbruvica ® is safe and effective in children your use of the information on this site is subject to the terms of the legal notice and new privacy policy of pharmacyclics llc this site is published by pharmacyclics llc which has developed the content in conjunction with janssen biotech inc any information that is collected on this site may be shared between pharmacyclics llc and janssen biotech inc this information is intended for use by our customers patients and healthcare professionals in the united states and puerto rico only pharmacyclics llc recognizes that the internet is a global communication medium however laws regulatory requirements and medical practices vary from country to country imbruvica ® ibrutinib is covered by u s patents which are listed in fdas orange book available at httpswwwaccessdatafdagovscriptscderobdefaultcfm © pharmacyclics llc 2018© janssen biotech inc 20180218 prc03738home  prescribing information  important side effect information  legal notice  privacy policy  contact us  unsubscribeupdate